Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Liraglutide (Saxenda) NICE Technology Appraisal TA664 recommends liraglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, within a specialist weight management service
Nat Genet 41:216220
Note that reconstituted injectable GHK-Cu can be used topically, but topical copper peptide products formulated for skin application may include additional ingredients optimizing penetration and stability that simple water reconstitution doesn't provide
Human clinical trials have not been completed, meaning efficacy and safety in people is not established through rigorous research
Refrigerate at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) immediately after reconstitution
Using oral peptides may reduce the inconvenience and financial burden
